Compare NSRX & GLNDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSRX | GLNDW |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Israel | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 43.0M |
| IPO Year | N/A | N/A |
| Metric | NSRX | GLNDW |
|---|---|---|
| Price | $3.07 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | ★ 41.8K | N/A |
| Earning Date | 03-25-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | N/A |
| 52 Week High | $9.99 | N/A |
| Indicator | NSRX | GLNDW |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | N/A |
| Support Level | $2.78 | N/A |
| Resistance Level | $3.58 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 32.17 | 0.00 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.